
Inside The Corrupt World Of Alzheimer’s Science And Institutional Failure
Federalist Radio Hour
00:00
Are You Getting an Endless Supply of Money on Alsheimers?
If somebody cures alsheimers, if one of the companies does it, they will make a lot of money on that drug. In development, though, and then in practice there are financial incentives that are not going to be strictly in the benefit of the consumer. That kind of sounds like what's at the o of the problem here,. If you're getting an endless supply of money in the development phase and failing over and over again, but are fine in your sort of insular community. Then you have skewed incentives. Again. En its its difficult to get to wade through it all.
Transcript
Play full episode